Medical Condition News

RSS

New drug candidate reduces toxic protein clumps of Huntington's disease

An experimental drug has been shown to alleviate symptoms of Huntington's disease and extend lifespan in mouse models. Further studies are required to determine whether these results may also apply to humans.

29 Jun 2026

Lung-on-a-chip tech reveals how asthma permanently alters airways

About 25 million people in the U.S. — roughly eight out of 100 — are diagnosed with asthma. Allergens, air pollution, extreme weather conditions, or other irritants can cause chronic lung inflammation, leading to coughing, wheezing, or shortness of breath.

29 Jun 2026

Study reveals how leukemia cells invade lungs and cause breathing problems

Led by NYU Langone Health researchers, a new study shows how blood cancer cells enter the lungs, damage tissue, and cause severe breathing problems.

29 Jun 2026

Scientists discover how Arc protein spreads Alzheimer's brain pathology

Alzheimer's disease is driven by a buildup of a toxic protein called Tau that kills neurons. As toxic Tau spreads to new regions of the brain, symptoms become worse and ultimately fatal.

29 Jun 2026

Study links diabetes to worse long COVID health outcomes

People with diabetes who have had COVID-19 tend to recover more slowly, experience more long COVID complications, have a poorer quality of life, and require closer and more prolonged monitoring by medical teams.

29 Jun 2026

Researchers develop new model to study aggressive melanomas

Researchers have created a powerful new cellular model to study rare tumors that are resistant to immunotherapies.

29 Jun 2026

New Alzheimer drug lecanemab brings modest benefits and high risks

Canada recently approved lecanemab to treat early Alzheimer disease, but the clinical benefits are modest, it carries a risk of serious adverse effects, and treatment is complex.

29 Jun 2026

Lithium MRI scans offer personalized treatments for bipolar disorder

A revolutionary scanning technique has revealed that lithium MRI is a powerful tool for studying how the drug interacts with the brain and could offer more personalized treatment for bipolar disorder.

29 Jun 2026

Brighter daytime light is linked to a lower dementia risk

The study finds that greater exposure to daytime light may lower dementia risk, pointing to light's role in enhancing circadian rhythms and cognitive function.

29 Jun 2026

Unusual CD34+ dysplastic giant platelets complicate myelodysplastic syndrome diagnosis

Myelodysplastic syndromes (MDS) are a group of hematopoietic disorders characterized by ineffective hematopoiesis, with manifestations of cytopenias in one, two, or three lineages.

28 Jun 2026

Women with Parkinson's may be more vulnerable to Alzheimer's pathology

Women with Parkinson's disease may be more vulnerable to Alzheimer's-related changes in the brain than men, according to new research presented at the European Academy of Neurology (EAN) Congress 2026.

28 Jun 2026

Multiple sclerosis affects social life and work beyond physical health

Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people reporting that the disease affects their social life and 48% reporting that it affects their work, according to new research presented at the European Academy of Neurology (EAN) Congress 2026.

28 Jun 2026

Simple bedside eye test may predict consciousness recovery after brain injury

A simple bedside eye test may help predict recovery of consciousness in patients with severe brain injuries, according to new research presented at the European Academy of Neurology (EAN) Congress 2026.

28 Jun 2026

Nasal viruses may drive allergic rhinitis, and ribavirin shows early promise as a targeted spray treatment

Nasal commensal viruses may worsen allergic rhinitis by activating type I IFN-linked neutrophils and NET formation. Ribavirin reduced nasal viral abundance and improved symptoms in mice and in a small phase 2 trial.

28 Jun 2026

Pioneering gene therapy for rare immune disorder shows promise in early pre-clinical studies

The development of a pioneering gene therapy to treat a devastating, rare immune disorder led by UCL scientists is set to move into its next phase following promising early pre-clinical studies.

27 Jun 2026

Gene fusion patterns refine classification of rare acute leukemias

Acute leukemias with chimeric fusion genes involving FET (FUS, EWSR1, and TAF15) family proteins and ETS (E26 transformation-specific)-like transcription factors often present with unique clinical and pathological characteristics.

27 Jun 2026

New Florida initiative supports healthier lives for cancer survivors statewide

University of West Florida Assistant Professor of Public Health Dr. Karishma Chhabria Unrue has been awarded a nearly $825,000 grant through the Florida Cancer Innovation Fund to lead a statewide initiative focused on improving the health and well-being of breast and prostate cancer survivors.

27 Jun 2026